ACET
Adicet Bio Inc
6.50$
-0.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.7% | -2.2% | -3.0% | -18.2% | +23.9% | +3.5% | -1.5% | -5.0% | -6.6% | -8.6% | -10.7% | – | |
| – | -11.7% | +15.6% | +5.7% | +12.9% | -44.3% | -15.7% | -8.6% | -13.0% | +123.4% | -76.9% | +10.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -210.1% | – | – | – | -104.2% | – | – | +710.3% | +461.7% | -245.6% | – | – | |
| – | -85.0% | +75.7% | +26.4% | +32.8% | -56.1% | +747.7% | -96.8% | +344.7% | -95.2% | +270.0% | +445.9% | – | |
| – | -85.0% | +75.7% | +26.4% | +31,880.5% | -77.1% | -87.1% | – | -48.9% | -364.5% | – | -11.8% | – | |
| – | +137,188.1% | -99.8% | – | – | – | – | – | – | -200.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +145,907.9% | -99.8% | -147.1% | – | -175.9% | – | -156.2% | – | -100.1% | – | – | |
| – | – | – | -126.8% | – | – | – | – | -185.3% | – | -127.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.